Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study

被引：0
|
作者：
Yoshihiro Tanaka
Kazuhiro Yoshida
Yuichi Sanada
Shinji Osada
Kazuya Yamaguchi
Takao Takahashi
机构：
[1] Gifu Graduate School of Medicine,Department of Surgical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Chemotherapy; Docetaxel; Cisplatin; 5-Fluorouracil; Esophageal carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1159 / 1165
页数：6
相关论文
共 50 条
  • [1] Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study
    Tanaka, Yoshihiro
    Yoshida, Kazuhiro
    Sanada, Yuichi
    Osada, Shinji
    Yamaguchi, Kazuya
    Takahashi, Takao
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1159 - 1165
  • [2] Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma
    Satomura, Hitoshi
    Nakajima, Masanobu
    Sasaki, Kinro
    Yamaguchi, Satoru
    Domeki, Yasushi
    Takahashi, Masakazu
    Muroi, Hiroto
    Kubo, Tsukasa
    Kikuchi, Maiko
    Otomo, Haruka
    Ihara, Keisuke
    Kato, Hiroyuki
    [J]. INTERNATIONAL SURGERY, 2015, 100 (06) : 1153 - 1158
  • [3] Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
    Yoshihiro Tanaka
    Kazuhiro Yoshida
    Atsuko Yamada
    Toshiyuki Tanahashi
    Naoki Okumura
    Nobuhisa Matsuhashi
    Kazuya Yamaguchi
    Tatsuhiko Miyazaki
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 77 : 1153 - 1155
  • [4] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 853 - 857
  • [5] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 853 - 857
  • [6] DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma
    Kim, S.
    Jary, M.
    Mansi, L.
    Benzidane, B.
    Cazorla, A.
    Demarchi, M.
    Nguyen, T.
    Kaliski, A.
    Delabrousse, E.
    Bonnetain, F.
    Letondal, P.
    Bosset, J. F.
    Valmary-Degano, S.
    Borg, C.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (12) : 3045 - 3050
  • [7] Modified DCF (Docetaxel, Cisplatin and 5-fluorouracil) chemotherapy is effective for the treatment of advanced rectal squamous cell carcinoma
    Herve, Laure
    Kim, Stefano
    Boustani, Jihane
    Klajer, Elodie
    Pernot, Mandy
    Nguyen, Thierry
    Lakkis, Zaher
    Borg, Christophe
    Vienot, Angelique
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma (vol 77, pg 1143, 2016)
    Tanaka, Yoshihiro
    Yoshida, Kazuhiro
    Yamada, Atsuko
    Tanahashi, Toshiyuki
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Yamaguchi, Kazuya
    Miyazaki, Tatsuhiko
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1153 - 1155
  • [9] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Sasaki, Ken
    Uchikado, Yasuto
    Omoto, Itaru
    Arigami, Takaaki
    Osako, Yusaku
    Noda, Masahiro
    Okumura, Hiroshi
    Maemura, Kosei
    Higashi, Ryutaro
    Yoshiura, Takashi
    Natsugoe, Shoji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 581 - 587
  • [10] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
    Ken Sasaki
    Yasuto Uchikado
    Itaru Omoto
    Takaaki Arigami
    Yusaku Osako
    Masahiro Noda
    Hiroshi Okumura
    Kosei Maemura
    Ryutaro Higashi
    Takashi Yoshiura
    Shoji Natsugoe
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 83 : 581 - 587
12345